Corrigendum to “The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials” [J Infect 89 (2024) 106187] (Journal of Infection (2024) 89(1), (S016344532400121X), (10.1016/j.jinf.2024.106187))

  • Kristoffer Grundtvig Skaarup
  • , Mats Christian Højbjerg Lassen
  • , Daniel Modin
  • , Niklas Dyrby Johansen
  • , Matthew M. Loiacono
  • , Rebecca C. Harris
  • , Jason K.H. Lee
  • , Marine Dufournet
  • , Orly Vardeny
  • , Alexander Peikert
  • , Brian Claggett
  • , Scott D. Solomon
  • , Jens Ulrik Stæhr Jensen
  • , Tor Biering-Sørensen

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that there is a mistake in the results section (paragraph with subheader “All-cause death”), which incorrectly interprets results presented in the supplementary material. With regards to the relative effect of high-dose vs. standard-dose influenza vaccine against all-cause death, the sentence currently reads: “Positive effects were observed in those free of cardiovascular disease and in individuals aged 65–79 years, respectively statistically significant and insignificant." The correct phrasing should be “respectively statistically non-significant and significant.” The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Article number106270
JournalJournal of Infection
Volume89
Issue number5
DOIs
StatePublished - Nov 2024

Bibliographical note

Publisher Copyright:
© 2024 The Author(s)

Fingerprint

Dive into the research topics of 'Corrigendum to “The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials” [J Infect 89 (2024) 106187] (Journal of Infection (2024) 89(1), (S016344532400121X), (10.1016/j.jinf.2024.106187))'. Together they form a unique fingerprint.

Cite this